Journal article · 2026
Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed
BMJ, 395, e101250 · Published 27 October 2026 · DOI 10.1136/bmj-2026-101250
In brief
“Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed” is a 2026 journal article by Chris Baraniuk, published in BMJ. OpenAlex counts 2 citations as of 16 November 2026, which puts it in the top 5% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 2
- Most cited in
- 2026 (2)
- Field-weighted impact
- 7.17
- References
- 1
- Authors
- 1
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Baraniuk, C. (2026). Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed. BMJ, 395, e101250. https://doi.org/10.1136/bmj-2026-101250
MLA 9
Baraniuk, Chris. “Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed.” BMJ, vol. 395, 2026, p. e101250. https://doi.org/10.1136/bmj-2026-101250.
Chicago
Baraniuk, Chris. 2026. “Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed.” BMJ 395: e101250. https://doi.org/10.1136/bmj-2026-101250.
Harvard
Baraniuk, C. (2026) ‘Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed’, BMJ, 395, p. e101250. doi:10.1136/bmj-2026-101250.
IEEE
C. Baraniuk, “Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed,” BMJ, vol. 395, p. e101250, 2026, doi: 10.1136/bmj-2026-101250.
BibTeX
@article{baraniuk2026ebola,
title = {{Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed}},
author = {Baraniuk, Chris},
journal = {BMJ},
year = {2026},
volume = {395},
pages = {e101250},
doi = {10.1136/bmj-2026-101250},
url = {https://doi.org/10.1136/bmj-2026-101250}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Ebola virus disease
- Bundibugyo virus
- Ebola vaccine
- vaccine clinical trials
- vaccine safety
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Baraniuk, C. (2026). Ebola: First people vaccinated in phase 2/3 Bundibugyo jab trial as health worker killed. BMJ, 395, e101250. https://doi.org/10.1136/bmj-2026-101250
How many times has this paper been cited?
2 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Chris Baraniuk.
What is the DOI of this paper?
10.1136/bmj-2026-101250, permanently at https://doi.org/10.1136/bmj-2026-101250. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.